Alzheimer's Disease: A Dreadful Disability by Dr. Frank S. K. Barar SignUp
Boloji.com
Boloji
Home Kabir Poetry Blogs BoloKids Writers Contribute Search Contact Site Map Advertise RSS Login Register
Boloji
Channels

In Focus

Analysis
Cartoons
Education
Environment
Going Inner
Opinion
Photo Essays

Columns

A Bystander's Diary
Business
My Word
PlainSpeak
Random Thoughts

Our Heritage

Architecture
Astrology
Ayurveda
Buddhism
Cinema
Culture
Dances
Festivals
Hinduism
History
People
Places
Sikhism
Spirituality
Vastu
Vithika

Society & Lifestyle

Family Matters
Health
Parenting
Perspective
Recipes
Society
Teens
Women

Creative Writings

Book Reviews
Ghalib's Corner
Humor
Individuality
Literary Shelf
Love Letters
Memoirs
Musings
Quotes
Ramblings
Stories
Travelogues
Workshop

Computing

CC++
Computing Articles
Flash
Internet Security
Java
Linux
Networking
Health Share This Page
Alzheimer's Disease: A Dreadful Disability
by Dr. Frank S. K. Barar Bookmark and Share
 


Alzheimer's Disease is named after Dr. Alois Alzheimer (1864-1915), a German neurologist, who in 1906 described changes in the brain tissue of a woman who died of an unusual mental illness. This disease is marked by the loss of cognitive (thought, memory, language) ability, generally over a period of 10 to 15 years.

Alzheimer's disease (AD) is a progressive condition in which nerve cells in the brain degenerate, and the size of the brain substance shrinks. AD is the single most common cause of dementia, i.e., a decline in all types of mental activity. Earlier, AD was classified as presenile dementia, but is now responsible for 75 percent of dementia cases in people over 65 years of age. In AD the progressive impairment of memory, and cognitive functions, ultimately leads to a vegetative state. Impairment of short-term memory (STM) is the first symptom of the disease, whereas, long-term memory (LTM), i.e., retrieval of distant memories remains relatively preserved.

AD is marked by atrophy of the cerebral cortical and subcortical neurones, labelled as dementia of Alzheimer's type. Senile plaques (Sheets) which are aggregates of beta-amyloid are evident in the brain. They are more abundant in the hippocampus and association areas of the cortex, leading to impairment of memory. It is proposed that deficiency of acetylcholine (a neurotransmitter) is responsible for the confusional state suffered by the subject. Additionally, there are changes in the brain glutamate, dopamine, noradrenaline and 5-hydroxytryptamine function.

Statistics are quite alarming. According to WHO estimates 3.7 million Indians suffer from AD, which is 22 percent of the global patient load. More than 50 percent people with AD live in the Developing World, which is expected to rise to over 70 percent by 2025. Seventy percent of all dementia patients can be attributed to AD. (Ref: India Today, Oct. 8, 2012). People with heart disease and diabetes are more prone to the disease. With gradual loss of memory, thought, and language the person is unable to carry out daily chores of life. The causes of AD are not fully known, Perhaps genetics and family history have a role to play.

Stages of the Disease

Three stages have been identified. However, the rate of progress, ranging from 2 to 10 years varies from person to person. Stage III is the stage of total dependence and inactivity. It is marked by losing control on body functions. One may be confined to a wheelchair or bed, with a vulnerability to infections.

Treatment

Presently there is no cure for Alzheimer's disease. Drugs employed to check further progress of the disease are: Denepezil, Galantamine, Memantine, and Rivastigmine. Symptomatic treatment for depression, insomnia, and agitation is desirable. Role of drugs like Seligiline, and efficacy of Vitamin E is under scrutiny.

Image (c) Gettyimages.com

11-Oct-2012
More by :  Dr. Frank S. K. Barar
 
Views: 1273
Article Comment Herewith some additional information about Alzheimer's Disease (AD):
A British team of scientists from King's College, London (2010) is developing a simple blood test which could predict AD up to 10 years before symptoms appear. They found very high levels of a blood protein called "clusterin" in individuals even 10 years before the first symptom of AD apears. This would allow a much earlier diagnosis and institution of treatment of the disease.

Lately, the British-Japanese duo --- John Gurdon (Britain) and Shinya Yamanaka (Japan) --- have won the Nobel prize in Medicine (2012) for "stem cell research". Their findings have revolutionised our understanding of how cells and organisms develop. Growing replacement tissue in the body may hold hope for victims of Alzheimer's and Parkinson's disease (Ref: TOI, Oct.9, 2012).
Dr. Frank S.K. Barar
10/13/2012
 
Top | Health







A Bystander's Diary Analysis Architecture Astrology Ayurveda Book Reviews
Buddhism Business Cartoons CC++ Cinema Computing Articles
Culture Dances Education Environment Family Matters Festivals
Flash Ghalib's Corner Going Inner Health Hinduism History
Humor Individuality Internet Security Java Linux Literary Shelf
Love Letters Memoirs Musings My Word Networking Opinion
Parenting People Perspective Photo Essays Places PlainSpeak
Quotes Ramblings Random Thoughts Recipes Sikhism Society
Spirituality Stories Teens Travelogues Vastu Vithika
Women Workshop
RSS Feed RSS Feed Home | Privacy Policy | Disclaimer | Site Map
No part of this Internet site may be reproduced without prior written permission of the copyright holder.
Developed and Programmed by ekant solutions